New Narcolepsy Medication 2024 India

New Narcolepsy Medication 2024 India. Food and drug administration for the treatment of excessive daytime sleepiness (eds) or cataplexy in. After recently submitting an amendment to the fda’s request for final approval, avadel pharmaceuticals announced the agency has.

If the agency gives karxt the green light, the drug will be the first truly new treatment for schizophrenia in decades. Following our update in november 2021, we are now delighted to announce that all four countries of the united kingdom have agreed to make solriamfetol available for the.